Kana Miyashita
About Kana Miyashita
Kana Miyashita is a Project Manager in R&D Strategy and Planning at Bristol-Myers Squibb in Tokyo, Japan, with extensive experience in clinical operations and project management within the pharmaceutical industry.
Current Role at Bristol-Myers Squibb
Kana Miyashita is currently a Project Manager in R&D Strategy and Planning at Bristol-Myers Squibb, located within the 23 wards of Tokyo, Japan. In this role, Kana is responsible for overseeing and coordinating research and development projects, ensuring strategic alignment with organizational goals. This position leverages her extensive experience in clinical operations and project management within the pharmaceutical industry.
Previous Role at Bristol-Myers Squibb
From 2017 to 2018, Kana Miyashita worked as a Study Manager in Regional Clinical Operations, R&D, at Bristol-Myers Squibb in Tokyo, Japan. During this one-year tenure, Kana was involved in managing regional clinical studies, which included overseeing study protocols and ensuring compliance with regulatory requirements.
Experience at Takeda Pharmaceuticals
Kana Miyashita has significant experience working at Takeda Pharmaceuticals in various roles. From 2015 to 2017, she served as a Clinical Study Manager focusing on Budget Planning in Tokyo, Japan. Before that, she worked on SOP integration within clinical studies from 2014 to 2015. From 2012 to 2014, Kana held a position at Takeda Bio Development Center as a Clinical Study Manager. She initially joined Takeda in 2008, managing Clinical Operations in Osaka, Japan, until 2012.
Educational Background
Kana Miyashita earned a Master's degree from Tokyo University of Agriculture and Technology, studying there from 2006 to 2008. This academic background laid a solid foundation for her career in the pharmaceutical industry, equipping her with the necessary skills and knowledge for her roles in clinical operations and project management.
Expertise in Clinical Operations
Kana Miyashita has extensive experience in clinical operations and project management within the pharmaceutical industry. She has been involved in SOP management and clinical development throughout her career, demonstrating a strong capability in budget planning for clinical studies. Kana has also played pivotal roles in integrating standard operating procedures (SOPs) within clinical study management, showcasing her versatility and expertise in this field.